// App-Quantinova.ai

P911 : SYMPTOM BURDEN AND ITS IMPACT ON DAILY LIFE AMONG PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE (IMCD) – FINDINGS FROM AN INTERNATIONAL IMCD PATIENT SURVEY

Researchers

Presenter

  • Francis Shupo

Principal Investigators

  • Nicola Mason

  • Emily Jones

  • Grace Wayi-Wayi

  • Mileva Repasky

  • Matthew Franklin

  • John Brazier

  • Natasa Zibelnik

  • Sudipto Mukherjee

Medical Centers

  • BresMed Health Solutions,Sheffield,Соединённое Ко

  • EUSA Pharma,Hemel Hempstead,Storbritannien

  • BresMed Health Solutions,Sheffield ,Royaume-uni

  • EUSA Pharma,Hemel Hempstead,Royaume-uni

  • Hematology and Medical Oncology, Cleveland Clinic Main Campus,Cleveland,United States

  • Castleman Disease Collaborative Network ,Paso Robles,Estados Unidos

  • BresMed Health Solutions Ltd,Sheffield,Regno Unito

  • BresMed Health Solutions Ltd,Sheffield,Regno Unito

  • Castleman Disease Collaborative Network ,Paso Robles,Estados Unidos

  • BresMed Health Solutions Ltd,Sheffield,Verenigd Koninkrijk

  • BresMed Health Solutions Ltd,Sheffield,Verenigd Koninkrijk

  • EUSA Pharma, Hemel Hempsted, United Kingdom

  • School of Health and Related Research,Sheffield,Vereinigtes Königreich

  • Castleman Disease Collaborative Network ,Paso Robles,Estados Unidos

  • School of Health a

  • Castleman Disease Collaborative Network ,Paso Robles,Estados Unidos

  • BresMed Health Solutions Ltd,Sheffield,Regno Unito

  • EUSA Pharma,Hemel Hempstead,Reino Unido

  • School of Health and Related Research,Sheffield,United Kingdom

  • Castleman Disease Collaborative Network ,Paso Robles,Estados Unidos

  • BresMed Health Solutions Ltd,Sheffield,Verenigd Koninkrijk

  • BresMed Health Solutions Ltd,Sheffield,Regno Unito

  • BresMed Health Solutions,Sheffield,Соединённое Ко

  • School of Health and Related Research,Sheffield,United Kingdom

  • School of Health and Related Research,Sheffield,United Kingdom

  • BresMed Health Solutions,Sheffield ,Royaume-uni

  • Hematology and Medical Oncology, Cleveland Clinic M

  • EUSA Pharma,Hemel Hempstead,Verenigd Koninkrijk

  • BresMed Health Solutions, Sheffield, United Kingdom

  • Castleman Disease Collaborative Network ,Paso Robles,Estados Unidos

  • EUSA Pharma,Hemel Hempstead,Vereinigtes Königreich

  • BresMed Health Solutions, Sheffield, United Kingdom

  • BresMed Health Solutions Ltd,Sheffield,Verenigd Koninkrijk

  • EUSA Pharma,Hemel Hempstead,Соединённое Королевство

  • EUSA Pharma,Hemel Hempstead,Reino Unido

  • School of Health and Related Research,Sheffield,United Kingdom

  • School of Health and Related Research,Sheffield,Vereinigtes Königreich

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Peripheral Nervous System

  • Nephrology

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Genetic Disorder

Disease

  • Castleman disease

  • Renal insufficiency

  • Thrombocytopenia

  • Peripheral neuropathy

  • Idiopathic multicentric Castleman’ s disease

Biomarkers

  • Anti-Müllerian hormone

  • Cancer antigen 15-3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved